Dis-Chem fined R1.2 million after losing price gouging case for surgical masks

accreditation
A selection of masks.
A selection of masks.
iStock
  • Pharmacy chain Dis-Chem has been found guilty of price gouging and fined R1.2 million.
  • The competition watchdog received complaints about excessive pricing for face masks. 
  • The Competition Tribunal described the prices as "utterly unreasonable". 


Pharmacy chain Dis-Chem has been found guilty by the Competition Tribunal of price gouging, and fined R1.2 million, for hiking the cost of surgical face masks at the start of the Covid-19 pandemic. 

The case was referred to the tribunal by the Competition Commission in April, after the competition watchdog received complaints from the public about excessive pricing for masks. 

During a hearing before the tribunal in May, Dis-Chem argued it has been forced to hike prices because of disruptions in supply, as well price increases by suppliers. It claimed that its competitors had followed suit.

But the tribunal nevertheless ruled that the pharmacy chain contravened the Competition Act by charging excessive prices for three types of surgical face masks  - SFM 50, SFM 5 and Folio50 – which was to the detriment of consumers during March. 

The commission managed to demonstrate that Dis-Chem exerted market power by "increasing its prices to significant levels" during the pandemic."One such increase took place on the very day that South Africa's first Covid-19 case was announced," the tribunal noted. 

Dis-Chem had failed to show the price increases were reasonable, it added. 

"In our view, Dis-Chem’s massive price increases of surgical masks during the complaint period … are utterly unreasonable and reprehensible," it said. "Poorer customers would have been excluded from accessing the masks by such exorbitant increases, other customers would have spent more on these items as a percentage of their disposable income."  

The tribunal said it would publish its comprehensive reasons for its decision in due course.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Rand - Dollar
14.71
+0.8%
Rand - Pound
20.25
+0.3%
Rand - Euro
17.08
+0.7%
Rand - Aus dollar
11.02
+0.1%
Rand - Yen
0.13
+0.6%
Gold
1,806.73
+0.8%
Silver
24.57
+0.9%
Palladium
2,065.50
+2.2%
Platinum
1,062.25
+1.8%
Brent Crude
85.53
+1.1%
Top 40
60,446
-0.1%
All Share
66,980
-0.1%
Resource 10
63,455
+0.8%
Industrial 25
85,827
-1.0%
Financial 15
13,901
+0.4%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
Facebook is facing a fresh crisis after a former employee turned whistle-blower leaked internal company research . Do you still use Facebook?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, the benefits outweigh the risk for me
25% - 272 votes
No, I have deleted it
45% - 482 votes
Yes, but I am considering deleting it
30% - 322 votes
Vote